Infectious Economics, LLC was founded in 2017 to partner with governments and businesses in the prevention and detection of disease outbreaks.
Applying expertise in epidemiology, health policy, and economics, our team designs cost-effective strategies to maximize health and productivity – weighing the costs and benefits of possible risk-reduction measures. Based in New York City, the Infectious Economics team offers services to rapidly generate evidence for data-driven decisions.
Blythe Adamson, PhD, MPH, Founder and Epidemiologist
Dr. Blythe Adamson is an infectious disease epidemiologist and economist. A former member of the White House COVID Task Force on Healthcare Resilience and lead data scientist in the West Wing, she currently serves on the COVID Sports and Society Working Group, advises public and private institutions on safe reopening plans for large-scale in-person gatherings including all major sports leagues, theme parks, retailers, and universities, and is an advisory board member to both NBA-Yale SalivaDirect and Testing for America.
Dr. Adamson founded Infectious Economics in 2017 to provide thought leadership to policy makers and industry leaders on cost-effective strategies to prevent the transmission of viruses. Dr. Adamson holds degrees in microbiology, epidemiology, and pharmaceutical economics with a focus on infectious disease prevention. Dr. Adamson has held roles at the Bill and Melinda Gates Foundation Institute for Disease Modeling, the HIV Vaccine Trials Network, and Flatiron Health.
Lisa Kussell, COO and Head of Strategic Partnerships
Lisa Kussell is the Chief Operating Officer and Head of Strategic Partnerships for Infectious Economics. She connects organizations, influencers, and media with world-class scientists through partnerships to improve population health and accelerate economic recovery of businesses. For more than 20 years, Kussell has strategically connected individuals, organizations, and brands to one another. Current & past clients include, but are not limited to: The Michael J. Fox Foundation for Parkinson’s Research, The National Board of Review, Condé Nast, DoSomething, January Digital, and Maisonette.
Charlene Speyerer, Head of Theatrical Productions
Charlene Speyerer is the Head of Theater Health at Infectious Economics.
A seasoned Broadway Stage Manager with more than 25 years of experience,
Speyerer’s extensive theater insight and mastery of COVID-19 safety and testing protocols make her uniquely qualified to serve the theater community.
A certified Covid Compliance Supervisor, Speyerer identifies and trains each of IE’s Covid Safety Managers to become proficient in their specific role.
Robby Sikka, MD, Head of Major League Sports
Robby Sikka is the Head of Major League Sports at Infectious Economics. As Chair the COVID Sports and Society Working Group, he brings together leaders from the NBA, NFL, MLS, MLB, PGA, and NASCAR with officials from The White House and CDC to generate actionable shared learnings from sports about Covid prevention in society. Dr. Sikka has valuable experience as the Vice President of Basketball Performance and Technology for the NBA Minnesota Timberwolves.
Christopher Mason, PhD, Head of Genomics
Dr. Christopher Mason is the Head of Genomics, an Associate Professor at Weill Cornell Medicine, Co-founder of Ongevity Health & Biotia, Vice President of Tempus, and Chairman of Nano-Lit. He has a PhD in Genetics from Yale University. Dr. Mason partners in genomic contact tracing investigations for industry to generate evidence of virus transmission sources.
Pam Remler, Broadway Covid Safety Manager
Pamela Remler is the Covid Safety Manager and Compliance for the first play to reopen on Broadway in 2021.
Jocelyn Lonquist, Chief of Staff
Jocelyn Lonquist is the Chief of Staff at Infectious Economics, reporting directly to the scientific founder. She partners with the senior leadership team to drive fast-moving projects of highest strategic priority.